trial

Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital

NCTId NCT01526395
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 99 (actual)
Sponsored by Johns Hopkins University
Primary completion 2012-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
99 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2011-08
Primary completion
2012-04
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Propofol

Sponsors

Johns Hopkins UniversityLead Sponsor
Johns Hopkins Bloomberg School of Public HealthCollaborator
Chhatrapati Shahuji Maharaj Medical UniversityCollaborator

Investigators

1
Irving M Reti, MBBSPrincipal Investigator

Sites

1 total
Lucknow, India

Facts & assertions

4 sourced
Enrollment
99
Phase
NA
Primary Completion Date
2012-04
Status
COMPLETED
relationships
The graph out of here
drug
Propofol
drug
lead_sponsor
Johns Hopkins University
company
collaborator
Johns Hopkins Bloomberg School of Public Health
company
Chhatrapati Shahuji Maharaj Medical University
company
indication
Bipolar Disorder
indication
Major Depressive Disorder
indication
Depressive Disorder, Major
indication
investigator
Irving M Reti, MBBS
person